Exclusive

Publication

Byline

PHC announces exclusive distribution of MaxCyte ExPERT platform in Japan

Singapore, July 2 -- The Biomedical Division of Japan-based PHC Corporation (PHCbi), a subsidiary of PHC Holdings Corporation (PHCHD), has signed an exclusive agreement with MaxCyte, Inc. to distribut... Read More


Indian biopharma firm Biological E partners with China's Recbio to produce HPV9 vaccine

Singapore, July 2 -- Jiangsu Recbio Technology, a leading Chinese biopharmaceutical company, has entered into a licensing cooperation agreement, and have commenced the technology transfer of their Rec... Read More


WuXi XDC accelerates global expansion of bioconjugates manufacturing by revitalising Singapore site

Singapore, July 2 -- WuXi XDC Cayman Inc. a leading global Contract Research, Development and Manufacturing Organisation (CRDMO) focused on the bioconjugate industry, has announced that the mechanical... Read More


Korea's Seegene launches STAgora, new platform for infectious disease analytics

Singapore, July 2 -- South Korea-based Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, has announced the launch of STAgora, a next-generation platform for infectious disease an... Read More


China's WuXi Biologics launches next-generation platform for high-concentration biologics

Singapore, July 1 -- WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO) in China, has announced the launch of WuXiHigh 2.0, a high-throughput formu... Read More


ETT and Fujifilm extend access to innovative treatments for obesity in Middle East

Singapore, July 1 -- Endo Tools Therapeutics (ETT),a Belgium-based company developing and marketing advanced endoscopic medical devices, and Fujifilm Middle East FZE, a subsidiary of Fujifilm Holdings... Read More


Korea's Chungnam National University inks MoU with global mass spectrometry leader Sciex

Singapore, July 1 -- Sciex, a global leader in life science analytical technologies, has signed a strategic Memorandum of Understanding (MoU) with Chungnam National University, South Korea. The agreem... Read More


AvenCell Japan wins $40 M AMED grant to advance allogeneic CAR-T programme

Singapore, July 1 -- AvenCell Japan, a wholly owned subsidiary of AvenCell Therapeutics, a private, clinical-stage biotechnology company developing best-in-class CAR-T therapies for hematologic cancer... Read More


Australia's Neurizon develops liquid formulation of NUZ-001 for treatment of Amyotrophic Lateral Sclerosis

Singapore, June 30 -- Neurizon Therapeutics, a clinical-stage biotech company based in Australia, has announced the development of a new oral liquid formulation of NUZ-001, its lead investigational th... Read More


China approves world's first dual GCG/GLP-1 receptor agonist for weight loss

Singapore, June 30 -- Innovent Biologics, Inc. has announced that China's National Medical Products Administration (NMPA) has approved mazdutide, a first-in-class dual glucagon (GCG)/glucagon-like pep... Read More